Sleep Aids (Pharmacies) - Zambia

  • Zambia
  • Revenue in the Sleep Aids market is projected to reach US$250.80k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.42%, resulting in a market volume of US$296.70k by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.01 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Zambia has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences:
Customers in Zambia are increasingly seeking sleep aids to address their sleep-related issues. This can be attributed to several factors, including the growing awareness of the importance of sleep for overall health and well-being. As people become more health-conscious, they are actively seeking solutions to improve their sleep quality. Additionally, the stressful and fast-paced nature of modern life has led to an increase in sleep disorders such as insomnia, further driving the demand for sleep aids.

Trends in the market:
One of the key trends in the Sleep Aids (Pharmacies) market in Zambia is the rising popularity of natural and herbal sleep aids. Customers are increasingly opting for products that are perceived as safer and have fewer side effects compared to conventional sleep aids. This trend is in line with the global shift towards natural and organic products in various sectors, including healthcare. Manufacturers and retailers are capitalizing on this trend by introducing a wide range of natural sleep aids, such as herbal teas, essential oils, and dietary supplements. Another trend in the market is the growing availability and accessibility of sleep aids in pharmacies. Pharmacies play a vital role in the healthcare system in Zambia, and they are increasingly stocking a variety of sleep aids to cater to the rising demand. This has made it easier for customers to access these products and seek professional advice from pharmacists. Moreover, the expansion of online pharmacies and e-commerce platforms has further enhanced the accessibility of sleep aids, allowing customers to conveniently purchase these products from the comfort of their homes.

Local special circumstances:
Zambia has a high prevalence of sleep disorders, which has contributed to the growth of the Sleep Aids (Pharmacies) market. Factors such as stress, irregular work schedules, and lifestyle changes have led to an increase in sleep-related issues among the population. Additionally, the aging population in Zambia is also driving the demand for sleep aids, as older adults are more prone to sleep disorders.

Underlying macroeconomic factors:
The growing middle class in Zambia has increased disposable income levels, allowing more people to afford sleep aids. Additionally, the increasing urbanization and westernization of lifestyles have also contributed to the demand for sleep aids. As people adopt a more sedentary lifestyle and spend more time indoors, they are more likely to experience sleep disturbances and seek remedies for better sleep. In conclusion, the Sleep Aids (Pharmacies) market in Zambia is experiencing growth due to changing customer preferences, such as the demand for natural sleep aids, and local special circumstances, including the high prevalence of sleep disorders. The increasing availability of sleep aids in pharmacies and the underlying macroeconomic factors, such as the growing middle class and urbanization, are further driving the market growth.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)